MYOS Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 14, 2014
11 nov. 2014 07h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 11, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Announces Positive Safety Data Demonstrating Fortetropin's(TM) Lack of Adverse Effect on Serum Lipids and Cholesterol Levels
04 nov. 2014 08h05 HE
|
MYOS Corporatation
CEDAR KNOLLS, NJ--(Marketwired - Nov 4, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces Statistically Significant Top-Line Clinical Data Demonstrating Fortetropin's(TM) Anti-Inflammatory BioTherapeutic Properties
30 oct. 2014 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Oct 30, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present Positive Clinical Data at 55th Annual Conference of the American College of Nutrition
02 oct. 2014 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Oct 2, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces Research Agreement With Human Metabolome Technologies America to Conduct Clinical Metabolomic Studies in Subjects Using Fortetropin(TM)
18 sept. 2014 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Sep 18, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014
04 sept. 2014 07h35 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Sep 4, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Reports 2014 Second Quarter Results
14 août 2014 06h45 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation to Announce Second Quarter 2014 Financial Results on August 14, 2014
07 août 2014 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 7, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Reports Additional Clinical Data on the Impact of Fortetropin on Lean Body Mass, Fat Mass and Muscle Size in Male Subjects
06 août 2014 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 6, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces Appointment of Douglas Weekes as Chief Commercial Officer
30 juil. 2014 08h04 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jul 30, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...